XBiotech Inc. XBIT
1.97 USD +0.06 (+3.14%)
At closeNov 10, 2026, 4:00 PM EST
1.97 0.00 0.00%
After hours · Nov 10, 4:00 PM ET
1.91 Day range 1.98
1.80 52-week range 3.44
- YTD
- -17.57%
- 1 year
- -19.59%
News
benzinga.com XBiotech Appoints Jan-Paul Simard Co-CEO, Effective Oct. 23 XBiotech Inc. (NASDAQ: XBIT) today announced that its Board of Directors have elected Jan-Paul Simard to serve as Co-Chief Executive Officer alongside CEO Dr. Sushma Shivaswamy, effective Oct. 23,…
benzinga.com XBiotech Announces Data From Its Phase II Portion Of Multicenter TASKIN Clinical Study Meets Pre-Specifed Primary Efficacy Success Criterion Under Simon Two-Stage Design; 61.3% Participants In Vilamakitug Experimental Arm Were Alive, Surpassing Threshold Of 42, More Surviving Patients XBiotech Inc. (NASDAQ: XBIT) today announced positive final efficacy results from the randomized Phase II portion of the multicenter TASKIN clinical trial. The investigator-sponsored study—funded by…
